Merit Medical Systems, Inc. $MMSI Shares Acquired by Sei Investments Co.

Sei Investments Co. lifted its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 53.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 228,544 shares of the medical instruments supplier’s stock after purchasing an additional 79,374 shares during the quarter. Sei Investments Co.’s holdings in Merit Medical Systems were worth $15,754,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Los Angeles Capital Management LLC purchased a new stake in Merit Medical Systems in the fourth quarter valued at approximately $25,000. Maseco LLP purchased a new position in Merit Medical Systems during the 4th quarter worth approximately $26,000. Torren Management LLC acquired a new stake in Merit Medical Systems during the 4th quarter valued at approximately $38,000. Covestor Ltd lifted its stake in Merit Medical Systems by 252.6% during the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after acquiring an additional 336 shares during the period. Finally, Danske Bank A S purchased a new stake in shares of Merit Medical Systems in the 3rd quarter valued at $42,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Insider Transactions at Merit Medical Systems

In other Merit Medical Systems news, insider Brian G. Lloyd purchased 2,000 shares of Merit Medical Systems stock in a transaction that occurred on Thursday, May 7th. The stock was bought at an average price of $62.62 per share, with a total value of $125,240.00. Following the acquisition, the insider owned 2,000 shares of the company’s stock, valued at $125,240. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Lynne N. Ward sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total value of $313,050.00. Following the completion of the sale, the director directly owned 7,809 shares in the company, valued at approximately $488,921.49. The trade was a 39.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research analysts recently issued reports on MMSI shares. Weiss Ratings cut shares of Merit Medical Systems from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, May 8th. Robert W. Baird set a $83.00 price target on Merit Medical Systems in a research report on Friday, May 1st. JPMorgan Chase & Co. reduced their price objective on Merit Medical Systems from $95.00 to $77.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Piper Sandler reissued an “overweight” rating on shares of Merit Medical Systems in a report on Friday, July 10th. Finally, Wall Street Zen downgraded Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 5th. Seven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Merit Medical Systems has a consensus rating of “Moderate Buy” and an average target price of $91.78.

Merit Medical Systems Stock Performance

MMSI opened at $83.35 on Friday. The firm has a fifty day moving average price of $69.45 and a 200 day moving average price of $71.69. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75. The stock has a market cap of $4.97 billion, a P/E ratio of 36.08, a P/E/G ratio of 2.51 and a beta of 0.52. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.08 and a quick ratio of 3.46.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, beating the consensus estimate of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The company had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. During the same quarter last year, the business earned $1.01 earnings per share. The firm’s revenue was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Equities research analysts anticipate that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current year.

Key Headlines Impacting Merit Medical Systems

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Q2 earnings and revenue beat estimates. Merit reported non-GAAP EPS of $1.19, up from $1.01 a year earlier and well above the $0.96 consensus estimate. Revenue rose 9.5% year over year to $418.8 million, exceeding expectations of $405.3 million. Merit Medical Surpasses Q2 Earnings and Revenue Estimates
• Positive Sentiment: Profitability improved. GAAP operating margin expanded to 14.4% from 12.3%, while non-GAAP operating margin increased to 22.6% from 21.2%. GAAP EPS rose 20%, and non-GAAP EPS increased 18% year over year. Merit Medical Reports Second Quarter 2026 Results
• Positive Sentiment: Full-year EPS guidance was raised or reaffirmed above consensus. Merit provided 2026 adjusted EPS guidance of $4.25 to $4.35, compared with the analyst consensus of $3.98. Revenue guidance of approximately $1.6 billion was in line with expectations, indicating that earnings growth and margin execution are key drivers of the outlook. Merit Medical Raises 2026 Outlook
• Neutral Sentiment: The earnings call transcript and additional metric analysis may provide more detail on product demand, regional performance, and management’s expectations, but the headline release did not indicate a material change to the revenue outlook. MMSI Q2 2026 Earnings Call Transcript
• Negative Sentiment: Cash generation weakened year to date. Operating cash flow fell 11% to $110.0 million, while free cash flow declined 14% to $76.6 million. Investors may monitor whether this reflects temporary working-capital needs or a more persistent pressure on cash conversion. Merit Medical Q2 Financial Highlights

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.